Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has provoked an ongoing global pandemic of coronavirus disease 2019 (COVID-19), which has affected 130 million people worldwide and caused nearly 3 million deaths in just over 1 year [1]. In 2020, COVID-19 has represented the third highest cause of death in the US after heart disease and cancer [2], and this outbreak has led to the largest drop in life expectancy since World War II [2]. Evidence-based medical treatment of COVID-19 (anticoagulants, corticosteroids, anti-inflammatory drugs, oxygenation therapy and ventilation) [3] seems to have improved patients’ outcomes, and the vast majority will recover spontaneously or after acute phase management. Acknowledgement: We thank the patients, relatives, healthcare providers, administrative hospital teams and the writing committee of the COMEBAC study.